<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67187">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01974739</url>
  </required_header>
  <id_info>
    <org_study_id>ABR 44878</org_study_id>
    <nct_id>NCT01974739</nct_id>
  </id_info>
  <brief_title>Hydrochloorthiazide and Hypernatriaemie</brief_title>
  <official_title>Hypernatraemia and Diuretics in Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Centre Leeuwarden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Centre Leeuwarden</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce
      hypernatremia and shorten the time of hypernatremia, we investigate the effect of
      hydrochloorthiazide compared to a placebo
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>sodium level</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>a decrease of 5 mmol/L sodium in plama</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time hypernatraemia</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>decrease of duration high sodium level in plasma</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Hypernatraemia</condition>
  <arm_group>
    <arm_group_label>hydrochloorthiazide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>once a day 25 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>once a day placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrochloorthiazide</intervention_name>
    <arm_group_label>hydrochloorthiazide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  sodium &gt; 142

        Exclusion Criteria:

          -  no informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christiaan Boerma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Centre Leeuwarden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matty Koopmans, RN</last_name>
    <phone>0031582866738</phone>
    <phone_ext>6738</phone_ext>
    <email>matty.koopmans@znb.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christiaan Boerma, MD</last_name>
    <phone>0031582866738</phone>
    <phone_ext>6738</phone_ext>
    <email>christiaan.boerma@znb.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical Centre Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <state>Friesland</state>
        <zip>8801 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christiaan Boerma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 8, 2014</lastchanged_date>
  <firstreceived_date>October 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical Centre Leeuwarden</investigator_affiliation>
    <investigator_full_name>E.C. Boerma</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>intensive care</keyword>
  <keyword>diuretics</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypernatremia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diuretics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
